Fraser Cunningham

908 total citations
20 papers, 673 citations indexed

About

Fraser Cunningham is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Fraser Cunningham has authored 20 papers receiving a total of 673 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Infectious Diseases and 4 papers in Organic Chemistry. Recurrent topics in Fraser Cunningham's work include Biochemical and Molecular Research (5 papers), Tuberculosis Research and Epidemiology (4 papers) and Pneumocystis jirovecii pneumonia detection and treatment (4 papers). Fraser Cunningham is often cited by papers focused on Biochemical and Molecular Research (5 papers), Tuberculosis Research and Epidemiology (4 papers) and Pneumocystis jirovecii pneumonia detection and treatment (4 papers). Fraser Cunningham collaborates with scholars based in United Kingdom, Spain and Belgium. Fraser Cunningham's co-authors include Valentine Brussee, Douglas W. Zochodne, Lluís Ballell, Robert H. Bates, Cory Toth, David S. McDonald, Jose A. Martinez, David Barros, Pieter Van der Veken and Maciej K. Rogacki and has published in prestigious journals such as PLoS ONE, Diabetes and Scientific Reports.

In The Last Decade

Fraser Cunningham

19 papers receiving 664 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fraser Cunningham United Kingdom 12 262 191 166 104 89 20 673
Veronica Soloveva United States 18 355 1.4× 319 1.7× 90 0.5× 181 1.7× 59 0.7× 34 915
Maureen Highkin United States 14 274 1.0× 183 1.0× 144 0.9× 95 0.9× 30 0.3× 23 794
Jonathan E. Nuss United States 18 407 1.6× 143 0.7× 103 0.6× 107 1.0× 128 1.4× 32 862
Elena Morelli Italy 17 462 1.8× 134 0.7× 104 0.6× 279 2.7× 100 1.1× 33 1.0k
Richard A. Lewis United Kingdom 20 461 1.8× 131 0.7× 67 0.4× 70 0.7× 277 3.1× 37 1.3k
Kundlik Gadhave India 16 304 1.2× 115 0.6× 178 1.1× 69 0.7× 41 0.5× 32 677
Christine Anne France 16 487 1.9× 152 0.8× 88 0.5× 183 1.8× 85 1.0× 21 1.2k
Zhenyu Li China 12 154 0.6× 128 0.7× 126 0.8× 62 0.6× 48 0.5× 28 512
Paul C. Meunier United States 18 303 1.2× 164 0.9× 68 0.4× 81 0.8× 150 1.7× 30 1.2k
Md. Zubbair Malik India 19 523 2.0× 172 0.9× 70 0.4× 71 0.7× 17 0.2× 89 928

Countries citing papers authored by Fraser Cunningham

Since Specialization
Citations

This map shows the geographic impact of Fraser Cunningham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fraser Cunningham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fraser Cunningham more than expected).

Fields of papers citing papers by Fraser Cunningham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fraser Cunningham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fraser Cunningham. The network helps show where Fraser Cunningham may publish in the future.

Co-authorship network of co-authors of Fraser Cunningham

This figure shows the co-authorship network connecting the top 25 collaborators of Fraser Cunningham. A scholar is included among the top collaborators of Fraser Cunningham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fraser Cunningham. Fraser Cunningham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bon, Marta, Fraser Cunningham, Brian Lu, et al.. (2025). AI Drug Discovery: Expanding the Horizons of Infectious Disease Therapeutics. ACS Infectious Diseases. 11(8). 2048–2050.
2.
Czarna, Anna, Jacek Plewka, Alex Matsuda, et al.. (2022). Refolding of lid subdomain of SARS-CoV-2 nsp14 upon nsp10 interaction releases exonuclease activity. Structure. 30(8). 1050–1054.e2. 27 indexed citations
3.
Nichols, Eva-Maria, et al.. (2022). Mathematical Modeling of Complement Pathway Dynamics for Target Validation and Selection of Drug Modalities for Complement Therapies. Frontiers in Pharmacology. 13. 855743–855743. 7 indexed citations
4.
Armstrong, Lee A., Sven M. Lange, Virginia De Cesare, et al.. (2021). Biochemical characterization of protease activity of Nsp3 from SARS-CoV-2 and its inhibition by nanobodies. PLoS ONE. 16(7). e0253364–e0253364. 51 indexed citations
5.
Cunningham, Fraser, Jorge Esquivias, Jaime Escribano, et al.. (2020). Exploring the SAR of the β-Ketoacyl-ACP Synthase Inhibitor GSK3011724A and Optimization around a Genotoxic Metabolite. ACS Infectious Diseases. 6(5). 1098–1109. 16 indexed citations
6.
Rogacki, Maciej K., Sophie Huss, Eva María López-Román, et al.. (2020). Optimization of Hydantoins as Potent Antimycobacterial Decaprenylphosphoryl-β-d-Ribose Oxidase (DprE1) Inhibitors. Journal of Medicinal Chemistry. 63(10). 5367–5386. 22 indexed citations
7.
Bakshi, Suruchi, Fraser Cunningham, Eva-Maria Nichols, et al.. (2020). Mathematical Modelling of Alternative Pathway of Complement System. Bulletin of Mathematical Biology. 82(2). 9 indexed citations
8.
Rogacki, Maciej K., Sophie Huss, Eva María López-Román, et al.. (2018). Identification and Profiling of Hydantoins—A Novel Class of Potent Antimycobacterial DprE1 Inhibitors. Journal of Medicinal Chemistry. 61(24). 11221–11249. 35 indexed citations
9.
Cunningham, Fraser, et al.. (2017). Design, synthesis and structure-activity relationship study of wollamide B; a new potential anti TB agent. PLoS ONE. 12(4). e0176088–e0176088. 29 indexed citations
10.
McConkey, Glenn A., et al.. (2017). Interconvertible geometric isomers of Plasmodium falciparum dihydroorotate dehydrogenase inhibitors exhibit multiple binding modes. Bioorganic & Medicinal Chemistry Letters. 27(16). 3878–3882. 4 indexed citations
11.
Ramón‐García, Santiago, Gaye Sweet, Fraser Cunningham, et al.. (2016). Repurposing clinically approved cephalosporins for tuberculosis therapy. Scientific Reports. 6(1). 34293–34293. 57 indexed citations
12.
Rogacki, Maciej K., Sophie Huss, Fraser Cunningham, et al.. (2016). Searching for New Leads for Tuberculosis: Design, Synthesis, and Biological Evaluation of Novel 2-Quinolin-4-yloxyacetamides. Journal of Medicinal Chemistry. 59(14). 6709–6728. 42 indexed citations
13.
14.
Cunningham, Fraser, Alvin W. Hung, H.L. Silvestre, et al.. (2014). Pantothenic Acid Biosynthesis in the Parasite Toxoplasma gondii: a Target for Chemotherapy. Antimicrobial Agents and Chemotherapy. 58(11). 6345–6353. 11 indexed citations
15.
Ordas, Anita, Fraser Cunningham, Hans J. Jansen, et al.. (2014). Testing Tuberculosis Drug Efficacy in a Zebrafish High-Throughput Translational Medicine Screen. Antimicrobial Agents and Chemotherapy. 59(2). 753–762. 51 indexed citations
16.
Cunningham, Fraser, Martin J. McPhillie, A. Peter Johnson, & Colin W. G. Fishwick. (2013). Anin silicostructure-based approach to anti-infective drug discovery. Parasitology. 141(1). 17–27. 3 indexed citations
17.
Cunningham, Fraser, et al.. (2012). Factors Influencing the Specificity of Inhibitor Binding to the Human and Malaria Parasite Dihydroorotate Dehydrogenases. Journal of Medicinal Chemistry. 55(12). 5841–5850. 40 indexed citations
18.
Toth, Cory, Valentine Brussee, Jose A. Martinez, et al.. (2006). Rescue and regeneration of injured peripheral nerve axons by intrathecal insulin. Neuroscience. 139(2). 429–449. 73 indexed citations
19.
Brussee, Valentine, Fraser Cunningham, & Douglas W. Zochodne. (2004). Direct Insulin Signaling of Neurons Reverses Diabetic Neuropathy. Diabetes. 53(7). 1824–1830. 184 indexed citations
20.
Cunningham, Fraser. (1977). The profile descent. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Veronica Soloveva Breakdown of academic impact, for papers by Maureen Highkin Breakdown of academic impact, for papers by Jonathan E. Nuss Breakdown of academic impact, for papers by Elena Morelli Breakdown of academic impact, for papers by Richard A. Lewis Breakdown of academic impact, for papers by Kundlik Gadhave Breakdown of academic impact, for papers by Christine Anne Breakdown of academic impact, for papers by Zhenyu Li Breakdown of academic impact, for papers by Paul C. Meunier Breakdown of academic impact, for papers by Md. Zubbair Malik
Rankless by CCL
2026